VVT Med (VVTM.F) Stock Overview

Develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. More details

VVTM.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Shares are highly illiquid

Negative shareholders equity

Revenue has declined by 40.3% over the past year

+ 2 more risks

VVTM.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW479,582 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

479,582 investors already sharing narratives

View all narratives

VVT Med Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for VVT Med
Historical stock prices
Current Share Price	CA$0.16
52 Week High	CA$0.30
52 Week Low	CA$0.001
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	15,580.00%

Recent updates

Shareholder Returns

	VVTM.F	US Medical Equipment	US Market
7D	0%	-1.0%	-1.4%
1Y	n/a	-21.8%	16.4%

Return vs Industry: Insufficient data to determine how VVTM.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how VVTM.F performed against the US Market.

Price Volatility

Is VVTM.F's price volatile compared to industry and market?
VVTM.F volatility
VVTM.F Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.4%
Market Average Movement	7.1%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.2%

Stable Share Price: VVTM.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine VVTM.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2007	8	Erez Tetro	www.vvtmed.com

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.

VVT Med Inc. Fundamentals Summary

How do VVT Med's earnings and revenue compare to its market cap?
VVTM.F fundamental statistics
Market cap	US$10.82m
Earnings (TTM)	-US$4.01m
Revenue (TTM)	US$77.00k

140.6x

P/S Ratio

-2.7x

P/E Ratio

Is VVTM.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VVTM.F income statement (TTM)
Revenue	US$77.00k
Cost of Revenue	US$24.00k
Gross Profit	US$53.00k
Other Expenses	US$4.06m
Earnings	-US$4.01m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	-0.055
Gross Margin	68.83%
Net Profit Margin	-5,207.79%
Debt/Equity Ratio	-26.8%

How did VVTM.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/23 22:06
End of Day Share Price	2026/07/06 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

VVT Med Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

VVT Med Inc.OTCPK:VVTM.F Stock Report